A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling
about
Repositioning of Memantine as a Potential Novel Therapeutic Agent against Meningitic E. coli-Induced Pathogenicities through Disease-Associated Alpha7 Cholinergic Pathway and RNA Sequencing-Based Transcriptome Analysis of Host Inflammatory ResponsesCinnamaldehyde Derivatives Inhibit Coxsackievirus B3-Induced Viral MyocarditisGranulin exacerbates lupus nephritis via enhancing macrophage M2b polarization.A20 is critical for the induction of Pam3CSK4-tolerance in monocytic THP-1 cellsCoxsackievirus-induced miR-21 disrupts cardiomyocyte interactions via the downregulation of intercalated disk components.Remission of CVB3-induced myocarditis with Astragaloside IV treatment requires A20 (TNFAIP3) up-regulationIntricacies of cardiac damage in coxsackievirus B3 infection: implications for therapy.In vitro interaction between coxsackievirus B3 VP1 protein and human pleckstrin homology domain retinal protein (PHR1).Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.A20 overexpression alleviates pristine-induced lupus nephritis by inhibiting the NF-κB and NLRP3 inflammasome activation in macrophages of mice.Gambogic acid inhibits the growth of ovarian cancer tumors by regulating p65 activity.A20 Attenuates Liver Fibrosis in NAFLD and Inhibits Inflammation Responses.A20 overexpression inhibits lipopolysaccharide-induced NF-κB activation, TRAF6 and CD40 expression in rat peritoneal mesothelial cells.Blunting Autoantigen-induced FOXO3a Protein Phosphorylation and Degradation Is a Novel Pathway of Glucocorticoids for the Treatment of Systemic Lupus Erythematosus.CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis.Liver X receptor activation enhances CVB3 viral replication during myocarditis by stimulating lipogenesis.Curcumin protects mice from coxsackievirus B3-induced myocarditis by inhibiting the phosphatidylinositol 3 kinase/Akt/nuclear factor-κB pathway.Genome-Wide Analysis of mRNA and Long Noncoding RNA Profiles in Chronic Actinic Dermatitis.Tumor necrosis factor receptor-associated factor 6 as a nuclear factor kappa B-modulating therapeutic target in cardiovascular diseases: at the heart of it all.Anti-inflammatory and anti-osteoclastogenic effects of zinc finger protein A20 overexpression in human periodontal ligament cells.
P2860
Q28547329-40B26EF3-28CA-4E7D-B836-0A39A2877AB9Q33655891-790E9792-E02C-46EE-95AF-C6F60D857F3DQ34766619-2E3F96B0-01E2-42CF-8E7D-FC8916F2EACBQ35086715-66F60D7A-85C0-4BDE-A14B-B7AE7595FB3CQ35145377-46412CFB-A17F-4A81-BA6E-2961E8308972Q35391084-6C68150D-6C0D-4B57-925A-B98436BEC436Q35483420-E87CB936-1AB4-42D0-AC8D-AE7A89E6150CQ35759309-5149F476-26F4-41EC-9502-530CC589AE0DQ36086324-F9C5C73C-9726-4033-831C-F4A5933054C1Q36411522-1F9FC2E0-38DA-424C-9971-0B80FBF19AA5Q37593936-7EF7D5B7-6985-4058-BF6B-73A47BE39919Q38714253-77E7D44F-0693-494E-818A-A4F1A6BF694BQ39358409-94915B3F-A29F-44FC-8A1C-AF37C5077050Q39534956-B85E5792-9765-42B2-8584-80C1A0063E72Q40096993-E1ED34AB-E8A9-4267-94DE-726389AFA247Q41208579-1D53C0E3-D208-4E1D-AFC8-EF8BB18BFB6FQ44428455-082DE971-09FA-4F8B-B8F8-445517490D00Q48189028-748F30B6-95CE-4123-8571-A83DD196A5C0Q49634849-DF4CB97C-4071-4323-8E12-5BFD8205EF06Q53810154-C95F95AA-C2C5-459A-B128-ABA417816A98
P2860
A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling
description
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
article scientifique (publié 2012)
@fr
articolo scientifico (pubblicato il 2012)
@it
artigo científico (publicado na 2012)
@pt
artículu científicu espublizáu en 2012
@ast
im Januar 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: 2012)
@en
vedecký článok (publikovaný 2012)
@sk
videnskabelig artikel (udgivet 2012)
@da
name
A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling
@ast
A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling
@en
A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling
@nl
type
label
A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling
@ast
A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling
@en
A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling
@nl
prefLabel
A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling
@ast
A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling
@en
A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling
@nl
P2093
P2860
P1433
P1476
A20 (TNFAIP3) alleviates CVB3-induced myocarditis via inhibiting NF-κB signaling
@en
P2093
P2860
P304
P356
10.1371/JOURNAL.PONE.0046515
P407
P577
2012-01-01T00:00:00Z